Jessica J. Tao

PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer

Ana Bosch, Zhiqiang Li, Anna Bergamaschi et al. · Science Translational Medicine · 2015 · 436 citations

Life Sciences, Molecular Biology, Oncology +17

mTORC1 Inhibition Is Required for Sensitivity to PI3K p110α Inhibitors in <i>PIK3CA</i> -Mutant Breast Cancer

Moshe Elkabets, Sadhna Vora, Dejan Juric et al. · Science Translational Medicine · 2013 · 347 citations · Full text

Medicine, Oncology, Pharmacology +17

High Frequency of<i>SDHB</i>Germline Mutations in Patients with Malignant Catecholamine-Producing Paragangliomas: Implications for Genetic Testing

Frederieke M. Brouwers, Graeme Eisenhofer, Jessica J. Tao et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 314 citations · Full text

Medicine, Genetics, Oncology +14

RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling

Zhan Yao, Yijun Gao, Wenjing Su et al. · Nature Medicine · 2018 · 196 citations

Medicine, Molecular Biology, Oncology +14

Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer

Jessica J. Tao, Pau Castel, Nina Radosevic‐Robin et al. · Science Signaling · 2014 · 166 citations

Medicine, Oncology, Pharmacology +16